Correlation Between Levels of N-terminal Pro-B-Type Natriuretic Peptide and Degrees of Heart Failure
Bong Geun Song, Eun Seok Jeon, Yong Hoon Kim, Min Kyung Kang, Joon Hyung Doh, Phil Ho Kim, Seok Jin Ahn, Hye Lim Oh, Hyun-Joong Kim, Ji Dong Sung, Sang Chol Lee, Hyeon Cheol Gwon, June Soo Kim, Duk-Kyung Kim, Sang Hoon Lee, Kyung Pyo Hong, Jeong Euy Park, Soo Youn Lee, Jong Koo Lee
Korean J Intern Med. 2005;20(1):26-32.   Published online 2005 Mar 31     DOI: https://doi.org/10.3904/kjim.2005.20.1.26
Citations to this article as recorded by Crossref logo
Integrated Transcriptome Map Highlights Structural and Functional Aspects of the Normal Human Heart
Maria Caracausi, Allison Piovesan, Lorenza Vitale, Maria Chiara Pelleri
Journal of Cellular Physiology.2017; 232(4): 759.     CrossRef
We need more data to determine the significance of NT-proBNP and troponin I levels in high-risk patients
Mehmet Eyuboglu
Revista Portuguesa de Cardiologia.2016; 35(3): 195.     CrossRef
We need more data to determine the significance of NT-proBNP and troponin I levels in high-risk patients
Mehmet Eyuboglu
Revista Portuguesa de Cardiologia (English Edition).2016; 35(3): 195.     CrossRef
N-terminal pro b-type natriuretic peptide (NT-pro-BNP) –based score can predict in-hospital mortality in patients with heart failure
Ya-Ting Huang, Yuan-Teng Tseng, Tung-Wei Chu, John Chen, Min-Yu Lai, Woung-Ru Tang, Chih-Chung Shiao
Scientific Reports.2016;[Epub]     CrossRef
British randomised controlled trial of AV and VV optimization (“BRAVO”) study: rationale, design, and endpoints
Zachary I Whinnett, S M Afzal Sohaib, Siana Jones, Andreas Kyriacou, Katherine March, Emma Coady, Jamil Mayet, Alun D Hughes, Michael Frenneaux, Darrel P Francis
BMC Cardiovascular Disorders.2014;[Epub]     CrossRef
The Biological Variation of N-Terminal Pro-Brain Natriuretic Peptide in Postmenopausal Women with Type 2 Diabetes: A Case Control Study
Susana González, Eric S. Kilpatrick, Stephen L. Atkin, Tamas Zakar
PLoS ONE.2012; 7(11): e47191.     CrossRef
Combination of Uric Acid and NT-ProBNP: A More Useful Prognostic Marker for Short-Term Clinical Outcomes in Patients with Acute Heart Failure
Hyoung-Seob Park, Hyungseop Kim, Ji-Hyun Sohn, Hong-Won Shin, Yun-Kyeong Cho, Hyuck-Jun Yoon, Chang-Wook Nam, Seung-Ho Hur, Yoon-Nyun Kim, Kwon-Bae Kim, Hee-Joon Park
The Korean Journal of Internal Medicine.2010; 25(3): 253.     CrossRef
Plasma Urotensin II as a Marker for Severity of Rheumatic Valve Disease
Orhan Ozer, Vedat Davutoglu, Suleyman Ercan, Murat Akcay, Ibrahim Sari, Murat Sucu, Ahmet Celik, Nur Aksoy, Hulya Cicek, Behcet Al
The Tohoku Journal of Experimental Medicine.2009; 218(1): 57.     CrossRef
Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure
David R. Buvat de Virginy
Heart Failure Reviews.2006; 11(4): 333.     CrossRef